Granuloma annulare associated with immune checkpoint inhibitors

被引：16

作者：

Wu, J. ^{[1
,2
,3
,4
,5
,6
]}

Kwong, B. Y. ^{[7
]}

Martires, K. J. ^{[7
]}

Rieger, K. E. ^{[7
,8
]}

Chung, W. H. ^{[2
,3
,4
,5
,6
]}

Iyer, G. V. ^{[9
,10
]}

Lacouture, M. E. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, 60th St Outpatient Ctr,Suite 407,Room 4312, New York, NY 10022 USA

[2] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, 5 Fuxing St, Keelung, Taiwan

[3] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, 5 Fuxing St, Linkou, Taiwan

[4] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, 5 Fuxing St, Taipei, Taiwan

[5] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, 5 Fuxing St, Taoyuan 333, Taiwan

[6] Chang Gung Univ, Coll Med, 261,Wenhua 1st Rd, Taoyuan 333, Taiwan

[7] Stanford Univ, Sch Med, Dept Dermatol, 291 Campus Dr, Stanford, CA 94305 USA

[8] Stanford Univ, Sch Med, Dept Pathol, 291 Campus Dr, Stanford, CA 94305 USA

[9] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA

[10] Weill Cornell Med Coll, Dept Med, 1300 York Ave, New York, NY 10065 USA

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 04期

基金：

美国国家卫生研究院;

关键词：

METASTATIC MELANOMA; NIVOLUMAB;

D O I：

10.1111/jdv.14617

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E124 / E126

页数：3

共 50 条

[21] Adverse Events Associated With Immune Checkpoint Inhibitors
Akturk, Halis Kaan
Michels, Aaron W.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (12): : 1219 - 1219
[22] Immune Checkpoint Inhibitors-Associated Cardiotoxicity
Li, Chenghui
Bhatti, Sajjad A.
Ying, Jun
CANCERS, 2022, 14 (05)
[23] Psychiatric disorders associated with immune checkpoint inhibitors
Zhou, C.
Lin, A.
Gu, T.
Zhang, J.
Luo, P.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1131 - S1131
[24] Peripheral neuropathies associated with immune checkpoint inhibitors
De Clerck, Lucie
Peuvrel, Lucie
Wiertlewski, Sandrine
Pereon, Yann
Magot, Armelle
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 : S16 - S16
[25] Management of Toxicities Associated With Immune Checkpoint Inhibitors
Yun, Karen M.
Bazhenova, Lyudmila
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (03) : 142 - 149
[26] Managing cardiotoxicity associated with immune checkpoint inhibitors
Upadhrasta Sireesha
Elias Hadi
Patel Keval
Zheng Lei
慢性疾病与转化医学（英文）, 2019, 5 (01) : 6 - 14
[27] Acquired lipodystrophy associated with immune checkpoint inhibitors
Gnanendran, Subashini S.
Miller, James A.
Archer, Christine A.
Jain, Swaranjali, V
Hwang, Shelley J. E.
Peters, Geoffrey
Miller, Andrew
MELANOMA RESEARCH, 2020, 30 (06) : 599 - 602
[28] Thrombotic Complications Associated with Immune Checkpoint Inhibitors
Wang, Tzu-Fei
Khorana, Alok A.
Carrier, Marc
CANCERS, 2021, 13 (18)
[29] Managing toxicities associated with immune checkpoint inhibitors
Park, Jiyeon Joy
Arafath, Syed
Kumar, Samir T.
Sharma, Roopali
Dixit, Deepali
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2021, 34 (06): : 32 - 39
[30] Treatment of Myositis Associated With Immune Checkpoint Inhibitors
Ana Matas-García
Eugenia Martinez-Hernandez
José César Milisenda
Current Treatment Options in Rheumatology, 2023, 9 : 179 - 191

← 1 2 3 4 5 →